DEATRAH DUBOSE: Open Payments
NPI 1831340561 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,832 in 135 payments from 24 companies in 2025. Trend: 2023 $1,898 · 2024 $1,703 · 2025 $2,832
Food & beverage: $2,832
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $678 |
| Novartis Pharmaceuticals Corporation | 35 | $572 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $252 |
| SCPHARMACEUTICALS INC. | 6 | $179 |
| E.R. Squibb & Sons, L.L.C. | 18 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $170 |
| Regeneron Pharmaceuticals, Inc. | 3 | $120 |
| Regeneron Healthcare Solutions, Inc. | 5 | $87 |
| UCB, Inc. | 4 | $78 |
| Novo Nordisk Inc | 4 | $72 |
Products named: REPATHA, LEQVIO, Kerendia, EVKEEZA, FUROSCIX, CAMZYOS, Bimzelx, TREMFYA.
Industry payments across NJ — which companies pay providers there.
